Neurological disorders
15 results
Applied filters
The licence and supporting evidence for natalizumab biosimilar
14 February 2024One licensed natalizumab biosimilar is available: Tyruko. Learn about the licensed indications and supporting evidence.
Choosing an antidepressant for people with epilepsy
26 March 2026Selective serotonin reuptake inhibitors (SSRIs) are the preferred antidepressant in people with epilepsy. We give considerations when selecting antidepressants.
Clonidine: informing intrathecal risk assessment
18 April 2026Clonidine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Baclofen: informing intrathecal risk assessment
18 April 2026Baclofen products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Parkinson’s disease medicines in swallowing difficulties
23 March 2026Information on administration of Parkinson’s disease medicines, including crushing tablets, to reduce the risk of missed doses in swallowing difficulties